Peripheral IV Catheters Market Report 2026

Peripheral IV Catheters Market Report 2026
Global Outlook – By Product Type (Short Peripheral Intravenous Catheters, Integrated Or Closed Peripheral Intravenous Catheters (PIVC)), By Technology (Conventional Peripheral Intravenous Catheters (PIVC), Safety Peripheral Intravenous Catheters (PIVC) ), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare) - Market Size, Trends, And Global Forecast 2026-2035
Peripheral IV Catheters Market Overview
• Peripheral IV Catheters market size has reached to $5.74 billion in 2025 • Expected to grow to $9.01 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Growing Prevalence Of Chronic Diseases Drives Expansion Of The Peripheral Iv Catheters Market • Market Trend: Innovative Multi-Access Blood Control Septum Advancing Peripheral IV Catheter Safety And Performance • North America was the largest region and fastest growing region.What Is Covered Under Peripheral IV Catheters Market?
Peripheral IV catheters refer to a thin, flexible tube that is placed into a vein to deliver medications and nutritional supplements. Peripheral intravenous catheters (PIVCs) are used for therapeutic purposes such as the administration of medications, fluids, or blood products, as well as blood sampling. The main types of peripheral IV catheters are short peripheral intravenous catheters and integrated/closed peripheral intravenous catheters (PIVC). A short peripheral catheter is less than 3 inches long. The technology used in peripheral IV catheters is conventional peripheral intravenous catheters, a safety PIVC that is used across various end-users such as hospitals, clinics, ambulatory surgical centers, and home healthcare.
What Is The Peripheral IV Catheters Market Size and Share 2026?
The peripheral iv catheters market size has grown strongly in recent years. It will grow from $5.74 billion in 2025 to $6.29 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to high incidence of hospital-acquired infections, reliance on conventional IV catheters, growing patient population requiring iv, limited availability of advanced safety catheters, fragmented healthcare infrastructure.What Is The Peripheral IV Catheters Market Growth Forecast?
The peripheral iv catheters market size is expected to see strong growth in the next few years. It will grow to $9.01 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancements in safety iv catheter technologies, increasing adoption of smart and antimicrobial catheters, expansion of home healthcare services, rising preference for integrated/closed iv systems, growing demand for minimally invasive therapy administration. Major trends in the forecast period include increasing adoption of ai-based catheter insertion guidance systems, rising use of cloud-based patient monitoring for iv therapy, growing development of antimicrobial and smart catheters, increasing integration of iot-enabled devices for iv monitoring, rising implementation of smart manufacturing for peripheral iv catheters.Global Peripheral IV Catheters Market Segmentation
1) By Product Type: Short Peripheral Intravenous Catheters, Integrated Or Closed Peripheral Intravenous Catheters (PIVC) 2) By Technology: Conventional Peripheral Intravenous Catheters (PIVC), Safety Peripheral Intravenous Catheters (PIVC) 3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare Subsegments: 1) By Short Peripheral Intravenous Catheters: Over-the-Needle Catheters, Winged Infusion Sets 2) By Integrated Or Closed Peripheral Intravenous Catheters (PIVC): Safety Catheters, Antimicrobial Catheters, Smart CathetersWhat Is The Driver Of The Peripheral IV Catheters Market?
The rising prevalence of chronic diseases is expected to propel the growth of the peripheral IV catheters market. Peripheral intravenous catheters are commonly used in the management of various chronic diseases, including cancer, cardiovascular diseases, and others. The rise in chronic diseases is largely driven by increasingly sedentary lifestyles, which contribute to long-term health risks by reducing physical activity and promoting conditions that lead to chronic illness. Peripheral IV catheters support chronic disease management by enabling quick and reliable access for delivering ongoing medications, fluids, or therapies needed to control long-term conditions. For instance, in 2025, according to the Northern Arizona Medical Group, a US-based healthcare provider, nearly three-quarters of the world’s population is projected to live with at least one chronic illness, and the prevalence of chronic illnesses continues to increase notably. In the United States, in 2023, about 76.4% of adults reported having at least one chronic condition, and 51.4% had two or more. Therefore, the rising prevalence of chronic diseases is expected to propel the growth of the peripheral IV catheters industry.Key Players In The Global Peripheral IV Catheters Market
Major companies operating in the peripheral iv catheters market are Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical Inc., Vygon SAS, Terumo Corporation, Teleflex Incorporated, NIPRO Medical Corporation, Argon Medical Devices Inc., Medical Components Inc., Vascular Pathways Inc., Tangent Medical Technologies Inc., Vigmed AB, Venner Medical, C. R. Bard Inc., MedSource Labs, Intra Special Catheters GmbH, Greiner Bio-One International GmbH, Ares Medikal, Ace Medical Company, Heka s.r.l, Raumedic AG, Vogt Medical Vertrieb GmbH, RenovoRx Inc., Retractable Technologies Inc., AngioDynamics Inc., ICU Medical Inc., Medtronic plc, Edwards Lifesciences Corporation, Cook Group Incorporated, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Merit Medical Systems Inc.Global Peripheral IV Catheters Market Trends and Insights
Major companies operating in the peripheral IV catheter market are focusing on developing innovative products, such as the multi-access blood control septum, which allows for multiple connections at the catheter hub without blood leakage and without needing to manually occlude the vein. A multi-access blood control septum refers to a valve built into the hub of certain IV catheters, and it is designed to automatically stop blood from leaking whenever the catheter hub is accessed. For instance, in July 2024, B. Braun Melsungen AG, a Germany-based pharmaceutical device company specializing in infusion therapy, announced the U.S. Food and Drug Administration (FDA) granted Introcan Safety® 2 Deep Access IV Catheter, a multi-access blood control septum that is specifically designed to prevent blood leakage during hub access, eliminate the need for manual vein occlusion, and maintain a closed system that enhances clinician safety. Additionally, it also reduces contamination risk during repeated line connections and disconnections.What Are Latest Mergers And Acquisitions In The Peripheral IV Catheters Market?
In May 2025, ICU Medical Inc., a US-based maker of vascular-access devices, including peripheral IV catheters and infusion-therapy consumables, partnered with Otsuka Pharmaceutical Factory Inc. to strengthen IV solutions and infusion therapy. With this joint venture, ICU Medical and Otsuka Pharmaceutical Factory formed Otsuka ICU Medical LLC, combining OPF’s global IV-solutions manufacturing scale (with 16 production sites across Asia) with ICU Medical’s North American production, distribution network, and infusion-therapy product expertise, aiming to strengthen supply-chain resiliency, provide large-scale, stable IV solutions supply, and bring new PVC-free IV technologies to the North American market, thereby supporting and expanding the broader peripheral IV/infusion therapy market. Otsuka Pharmaceutical Factory Inc., a Japan-based manufacturer of IV solutions and IV therapy products.Regional Outlook
North America was the largest region in the peripheral IV catheters market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Peripheral IV Catheters Market?
The peripheral IV catheters market consists of sales of long peripheral intravenous catheters (long PIVC), and midline catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Peripheral IV Catheters Market Report 2026?
The peripheral iv catheters market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral iv catheters industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Peripheral IV Catheters Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $6.29 billion |
| Revenue Forecast In 2035 | $9.01 billion |
| Growth Rate | CAGR of 9.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Technology, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical Inc., Vygon SAS, Terumo Corporation, Teleflex Incorporated, NIPRO Medical Corporation, Argon Medical Devices Inc., Medical Components Inc., Vascular Pathways Inc., Tangent Medical Technologies Inc., Vigmed AB, Venner Medical, C. R. Bard Inc., MedSource Labs, Intra Special Catheters GmbH, Greiner Bio-One International GmbH, Ares Medikal, Ace Medical Company, Heka s.r.l, Raumedic AG, Vogt Medical Vertrieb GmbH, RenovoRx Inc., Retractable Technologies Inc., AngioDynamics Inc., ICU Medical Inc., Medtronic plc, Edwards Lifesciences Corporation, Cook Group Incorporated, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Merit Medical Systems Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Peripheral IV Catheters market was valued at $5.74 billion in 2025, increased to $6.29 billion in 2026, and is projected to reach $9.01 billion by 2030.
request a sample hereThe global Peripheral IV Catheters market is expected to grow at a CAGR of 9.4% from 2026 to 2035 to reach $9.01 billion by 2035.
request a sample hereSome Key Players in the Peripheral IV Catheters market Include, Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical Inc., Vygon SAS, Terumo Corporation, Teleflex Incorporated, NIPRO Medical Corporation, Argon Medical Devices Inc., Medical Components Inc., Vascular Pathways Inc., Tangent Medical Technologies Inc., Vigmed AB, Venner Medical, C. R. Bard Inc., MedSource Labs, Intra Special Catheters GmbH, Greiner Bio-One International GmbH, Ares Medikal, Ace Medical Company, Heka s.r.l, Raumedic AG, Vogt Medical Vertrieb GmbH, RenovoRx Inc., Retractable Technologies Inc., AngioDynamics Inc., ICU Medical Inc., Medtronic plc, Edwards Lifesciences Corporation, Cook Group Incorporated, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Merit Medical Systems Inc. .
request a sample hereMajor trend in this market includes: Innovative Multi-Access Blood Control Septum Advancing Peripheral IV Catheter Safety And Performance. For further insights on this market.
request a sample hereNorth America was the largest region in the peripheral IV catheters market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral iv catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here